Abstract Diabetic retinopathy (DR) is the most common complication of diabetes mellitus and a leading cause of vision loss
Vinke et al., 2018
However, some secondary measures of nerve impairment did improve, especially in participants with higher cardiovascular risk and moderate BMI.7 Shorter-term trials have shown that 600mg/day of oral racemic ALA reduced neuropathy symptoms like burning, tingling, and numbness in as little as 35 weeks.4 20 A 2010 meta-analysis concluded that oral ALA can improve symptoms of diabetic neuropathy, but noted variability in effect sizes across trials and better results with intravenous administration.1 Despite promising results from some trials, a recent systematic review evaluating eight randomized controlled trials indicates that findings on ALA's effectiveness in treating diabetic neuropathy symptoms are inconsistent.23 While ALA proved safe and tolerable across these studies, the review concluded that definitive evidence supporting significant benefits is limited
R/ Nuestra L-Glutathione Complex est en la forma reducida y la usamos ya que es la forma biolgicamente activa
Backed by a team of dermatologists and skin care professionals, the premium cosmeceutical brand offers clinical-grade solutions for skin problems like hyperpigmentation, dullness, dryness, wrinkles, sun damage, rosacea and sensitivity
